Comparison Of Orally Administered Cannabis Extract And Delta-9-tetrahydrocannabinol In Treating Patients With Cancer-related Anorexia-cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-blind, Placebo-controlled Clinical Trial From The Cannabis-In-Cachexia-Study-Group
|Trial Design||Randomized trial|
|Trial Length||1-6 months|
|Number of Subjects||164|
|Age Range||30-44, 45-64, 65+|
Participants either received capsules containing a placebo, 2.5 mg THC and 1 mg CBD, or only 2.5 mg THC to be taken twice daily for six weeks. The primary outcome was appetite, measured using a visual analogue scale, and quality of life, measured using two quality of life questionnaires. Each outcome was measured every two weeks.